1[1]Schulte H D,Borisov K,Gramsch Z H,et al.Management of symptomatic hypertrophic obstructive cardiomyopathy-long-term results after surgical therapy.Thorac Cardiovasc Surg,1999,47(4):213-218.
2[2]Sigwart U.Non-surgical myocardial reduction for hypertrophic obstructive cardiomyopathy.Lancet,1995,346:211-214.
3[3]Seggewiss H,Gleichmann U,Faber L,et al.Percutaneous transluminal septal mocardial ablation in hypertrophic obstructive cardiomyopathy:Acute results and 3-month follow-up in 25 patients.J Am Coll Cardiol,1998,31(2):252-258.
4[4]Kazmierczak J,Kornacewixz J Z,Kisly M,et al.Electrocardiographic changes after alcohol septal ablation in hypertrophic obstructive cardiomyopathy.Heart,1998,80(3):257-262.
5[5]Tsuchikane E,Nakamura T,Yamazaki K,et al.Transluminal percutanious septal myocardial ablation in a patient with hypertrophic obstructive cardiom-yopathy.Jpn Circ J,1998,63(7):537-540.
6[6]Gspar J,Mrtiez R M A,Vonderwaide C,et al.Pericardium-covered stent for septa;myocardial ablation in hypertrophic obstructive cardiomyopathy.Cathet Cardiovasc lnterv,1999,47(1):73-79.
7[7]Gaber L,Seggewiss H,Ziemssen P,et al.lntraprocedural myocardial contrast echocaediography as a routine procedure in percutaneous transluminal septal myocardial ablation:Detection of threatening myocardial necrosis distant from the septal target area.Cathet Cardiovasc Interv,1999,47(4):462-466.
8[8]Feber L,Seggwiss H,Gleichmann U.Percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy:Results with respect to intraprocedural myocardial contrast echocardiography.Circulation,1998,96(22):2415-2421.
10[10]Gietzen F H,Leuner C J,Raute K U,et al.Acute and long-term results after transcoronary ablation of septal hypertrophy[TASH].Catheter interventional treatment for hypertrophic obstructive cardio-myopathy.Eur Heart J,1999,20(18):1342-1354.
